b 8 139
Pill imprint b 8 139 has been identified as Galantamine hydrobromide 8 mg.
Galantamine is used in the treatment of alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy.
Galantamine 8 mg is not subject to the Controlled Substances Act.
See also related documents.
Galantamine hydrobromide Images
- Imprint:
-
b 8
139 - Strength:
- 8 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
More Galantamine Hydrobromide resources
- Galantamine (Wolters Kluwer)
- Galantamine Extended-Release Capsules (Wolters Kluwer)
- Galantamine Solution (Wolters Kluwer)
- galantamine (Cerner Multum)
- galantamine (Micromedex) - Includes Dosage Information
- Galantamine Hydrobromide (AHFS DI)
- Galantamine (FDA)
- Galantamine Capsules (FDA)
- Galantamine Oral Solution (FDA)
- Galantamine Hydrobromide (Wolters Kluwer)


